ID
25215
Descripción
Adverse Experiences - Continued form Study ID: 208127/125 Clinical Study ID: 208127/125 (Ext-HAB-038 Month 90) Study Title: A double-blind, randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' combined hepatitis A / hepatitis B vaccine in healthy children between 6 and 15 years of age. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B
Palabras clave
Versiones (1)
- 28/8/17 28/8/17 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
28 de agosto de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Adverse Experiences - Continued Biologicals HepA/HepB vaccine 208127/125
Adverse Experiences - Continued Biologicals HepA/HepB vaccine 208127/125
Descripción
Adverse Experiences
Alias
- UMLS CUI-1
- C0877248
Descripción
Experience
Alias
- UMLS CUI-1
- C0877248
Descripción
Adverse Event
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0877248
Descripción
Local reaction
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0853813
- UMLS CUI [1,2]
- C2700396
Descripción
General reaction
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1710276
Descripción
day/month/year
Tipo de datos
date
Alias
- UMLS CUI [1]
- C3173309
Descripción
hours/minutes if the experience is observed during the immediate post vaccination period specified in the protocol, the exact time of onset has to be specified
Tipo de datos
time
Alias
- UMLS CUI [1]
- C0449244
Descripción
day/month/year
Tipo de datos
date
Alias
- UMLS CUI [1]
- C1531784
Descripción
hours/minutes
Tipo de datos
time
Alias
- UMLS CUI [1]
- C0449238
Descripción
Intensity
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0518690
Descripción
Relationship to Study Vaccine
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0439849
Descripción
Outcome
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1705586
Descripción
continuing at end of study
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1553904
Descripción
If yes, record in the Medication Section
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
Descripción
If yes, report experience to SB by phone within 24hrs and complete the SAEF form.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1547644
Descripción
For SB
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0237753
Descripción
Administrative Data
Alias
- UMLS CUI-1
- C1320722
Similar models
Adverse Experiences - Continued Biologicals HepA/HepB vaccine 208127/125
C0877248 (UMLS CUI [1,2])
C2700396 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])